Ascendis Pharma A/S vs Clear Secure Inc — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Clear Secure Inc trades at $47.85 (market cap $4.98B). The key difference: Ascendis Pharma A/S is far larger — about 3.3× Clear Secure Inc's market cap, and Clear Secure Inc pays a 1.19% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | YOU | |
|---|---|---|
Market Cap | $16.67B | $4.98B |
Sector | Health | Technology |
52-Week High | $277.18 | $62.36 |
52-Week Low | $189.74 | $29.61 |
Enterprise Value | $17.04B | $4.13B |
Dividend Yield | — | 1.19% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →